GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Polaris Group (TPE:6550) » Definitions » Cash Flow from Others

Polaris Group (TPE:6550) Cash Flow from Others : NT$28.30 Mil (TTM As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Polaris Group Cash Flow from Others?

Polaris Group's cash flow from others for the three months ended in Mar. 2025 was NT$1.29 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Mar. 2025 was NT$28.30 Mil.


Polaris Group Cash Flow from Others Historical Data

The historical data trend for Polaris Group's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polaris Group Cash Flow from Others Chart

Polaris Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow from Others
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.96 3.25 18.78 -86.69 -4.75

Polaris Group Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash Flow from Others Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -31.76 -5.06 32.19 -0.12 1.29

Polaris Group Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$28.30 Mil.

Polaris Group Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Polaris Group's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.


Polaris Group Business Description

Traded in Other Exchanges
N/A
Address
NO.298, Ruiguang Road, 7th floor, Neihu District, Taipei, TWN
Polaris Group is a multinational biotechnology company focused on developing novel anti-cancer therapies. The company's lead therapeutic Pegargiminase (ADI PEG 20), is a biologic in late-stage clinical development for a wide range of cancers, including hepatocellular carcinoma, mesothelioma, pancreatic cancer, non-small cell lung cancer, melanoma, acute myeloid leukemia and others. Polaris Group is also involved in every stage of the drug development process.

Polaris Group Headlines

No Headlines